Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Cell

Volumn 181, Issue 5, 2020, Pages 1036-1045.e9

  Blanco Melo, Daniel ^a   Nilsson Payant, Benjamin E ^a   Liu, Wen Chun ^a   Uhl, Skyler ^a   Hoagland, Daisy ^a   Møller, Rasmus ^a   Jordan, Tristan X ^a   Oishi, Kohei ^a   Panis, Maryline ^a   Sachs, David ^a   Wang, Taia T ^b,c   Schwartz, Robert E ^d   Lim, Jean K ^a   Albrecht, Randy A ^a   tenOever, Benjamin R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHAN ZUCKERBERG BIOHUB   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

chemokines; Coronavirus; COVID 19; ferret; IL6; interferon; SARS CoV 2; transcriptomics; virus host interactions

Indexed keywords

CHEMOKINE; INTERFERON; INTERLEUKIN 6;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; BLOOD ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INNATE IMMUNITY; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS IMMUNITY; ANIMAL; BETACORONAVIRUS; CELL CULTURE; CLASSIFICATION; CORONAVIRUS INFECTION; DISEASE MODEL; GENETIC TRANSCRIPTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PANDEMIC; PHYSIOLOGY; RNA VIRUS; VIROLOGY; VIRUS PNEUMONIA;

ANIMALS; BETACORONAVIRUS; CELLS, CULTURED; CHEMOKINES; CORONAVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERONS; PANDEMICS; PNEUMONIA, VIRAL; RNA VIRUSES; TRANSCRIPTION, GENETIC;

EID: 85084438244     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2020.04.026     Document Type: Article

References (53)

1. Amanat, F., Krammer, F., SARS-CoV-2 Vaccines: Status Report. Immunity 52 (2020), 583–589.
2. Blanco-Melo, D., Nilsson-Payant, B.E., Uhl, S., Escudero-Pèrez, B., Olschewski, S., Thibault, P., Panis, M., Rosenthal, M., Muñoz-Fontela, C., Lee, B., et al. An inability to maintain the ribonucleoprotein genomic structure is responsible for host detection of negative-sense RNA viruses. bioRxiv, 2020, 10.1101/2020.2003.2012.989319.
3. Channappanavar, R., Fehr, A.R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D.K., Perlman, S., Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe 19 (2016), 181–193.
4. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
5. Chu, D.K.W., Pan, Y., Cheng, S.M.S., Hui, K.P.Y., Krishnan, P., Liu, Y., Ng, D.Y.M., Wan, C.K.C., Yang, P., Wang, Q., et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin. Chem. 66 (2020), 549–555.
6. Corman, V.M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D.K.W., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M.L., et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill., 25, 2020, 25 2000045.
7. Cui, J., Li, F., Shi, Z.L., Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17 (2019), 181–192.
8. de Wit, E., van Doremalen, N., Falzarano, D., Munster, V.J., SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14 (2016), 523–534.
9. Frieman, M., Baric, R., Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation. Microbiol. Mol. Biol. Rev. 72 (2008), 672–685.
10. Frieman, M.B., Chen, J., Morrison, T.E., Whitmore, A., Funkhouser, W., Ward, J.M., Lamirande, E.W., Roberts, A., Heise, M., Subbarao, K., Baric, R.S., SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog., 6, 2010, e1000849.
11. García-Sastre, A., Ten Strategies of Interferon Evasion by Viruses. Cell Host Microbe 22 (2017), 176–184.
12. García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D.E., Durbin, J.E., Palese, P., Muster, T., Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252 (1998), 324–330.
13. Giavridis, T., van der Stegen, S.J.C., Eyquem, J., Hamieh, M., Piersigilli, A., Sadelain, M., CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. 24 (2018), 731–738.
14. Hallak, L.K., Collins, P.L., Knudson, W., Peeples, M.E., Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271 (2000), 264–275.
15. Harcourt, J., Tamin, A., Lu, X., Kamili, S., Sakthivel, S.K., Murray, J., Queen, K., Tao, Y., Paden, C.R., Zhang, J., et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. Emerg. Infect. Dis., 2020, 10.3201/eid2606.200516 Published online March 11, 2020.
16. Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N.H., Nitsche, A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181 (2020), 271–280.e8.
17. Hur, S., Double-Stranded RNA Sensors and Modulators in Innate Immunity. Annu. Rev. Immunol. 37 (2019), 349–375.
18. Janeway, C.A. Jr., Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
19. Jing, Y., Shaheen, E., Drake, R.R., Chen, N., Gravenstein, S., Deng, Y., Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum. Immunol. 70 (2009), 777–784.
20. Kamitani, W., Narayanan, K., Huang, C., Lokugamage, K., Ikegami, T., Ito, N., Kubo, H., Makino, S., Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl. Acad. Sci. USA 103 (2006), 12885–12890.
21. Kim, Y.I., Kim, S.G., Kim, S.M., Kim, E.H., Park, S.J., Yu, K.M., Chang, J.H., Kim, E.J., Lee, S., Casel, M.A.B., et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe, 2020 S1931-3128(20)30187-6.
22. Kopecky-Bromberg, S.A., Martínez-Sobrido, L., Frieman, M., Baric, R.A., Palese, P., Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81 (2007), 548–557.
23. Langlois, R.A., Albrecht, R.A., Kimble, B., Sutton, T., Shapiro, J.S., Finch, C., Angel, M., Chua, M.A., Gonzalez-Reiche, A.S., Xu, K., et al. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat. Biotechnol. 31 (2013), 844–847.
24. Langmead, B., Salzberg, S.L., Fast gapped-read alignment with Bowtie 2. Nat. Methods 9 (2012), 357–359.
25. Law, H.K., Cheung, C.Y., Ng, H.Y., Sia, S.F., Chan, Y.O., Luk, W., Nicholls, J.M., Peiris, J.S., Lau, Y.L., Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106 (2005), 2366–2374.
26. Lazear, H.M., Schoggins, J.W., Diamond, M.S., Shared and Distinct Functions of Type I and Type III Interferons. Immunity 50 (2019), 907–923.
27. Lefrançais, E., Ortiz-Muñoz, G., Caudrillier, A., Mallavia, B., Liu, F., Sayah, D.M., Thornton, E.E., Headley, M.B., David, T., Coughlin, S.R., et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544 (2017), 105–109.
28. Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Chen, L., Li, J., Wang, X., Wang, F., et al. The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing. medRxiv, 2020, 10.1101/2020.02.23.20026690.
29. Liu, W.C., Nachbagauer, R., Stadlbauer, D., Solórzano, A., Berlanda-Scorza, F., García-Sastre, A., Palese, P., Krammer, F., Albrecht, R.A., Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Front. Immunol., 10, 2019, 756.
30. Lokugamage, K., Hage, A., Schindewolf, C., Rajsbaum, R., Menachery, V.D., SARS-CoV-2 is sensitive to type I interferon pretreatment. bioRxiv, 2020, 10.1101/2020.03.07.982264.
31. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol., 15, 2014, 550.
32. Lu, X., Zhang, L., Du, H., Zhang, J., Li, Y.Y., Qu, J., Zhang, W., Wang, Y., Bao, S., Li, Y., et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med., 2020, 10.1056/NEJMc2005073 Published online March 18, 2020.
33. Menachery, V.D., Eisfeld, A.J., Schäfer, A., Josset, L., Sims, A.C., Proll, S., Fan, S., Li, C., Neumann, G., Tilton, S.C., et al. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses. MBio, 5, 2014 e01174–e14.
34. Montecino-Rodriguez, E., Berent-Maoz, B., Dorshkind, K., Causes, consequences, and reversal of immune system aging. J. Clin. Invest. 123 (2013), 958–965.
35. Norelli, M., Camisa, B., Barbiera, G., Falcone, L., Purevdorj, A., Genua, M., Sanvito, F., Ponzoni, M., Doglioni, C., Cristofori, P., et al. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat. Med. 24 (2018), 739–748.
36. Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41 (2020), 145–151.
37. Pascal, K.E., Coleman, C.M., Mujica, A.O., Kamat, V., Badithe, A., Fairhurst, J., Hunt, C., Strein, J., Berrebi, A., Sisk, J.M., et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc. Natl. Acad. Sci. USA 112 (2015), 8738–8743.
38. Proudfoot, A.E., Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2 (2002), 106–115.
39. Qian, Z., Travanty, E.A., Oko, L., Edeen, K., Berglund, A., Wang, J., Ito, Y., Holmes, K.V., Mason, R.J., Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am. J. Respir. Cell Mol. Biol. 48 (2013), 742–748.
40. Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis., 2020, 10.1093/cid/ciaa248 Published online March 12, 2020.
41. Sharma, S., tenOever, B.R., Grandvaux, N., Zhou, G.P., Lin, R., Hiscott, J., Triggering the interferon antiviral response through an IKK-related pathway. Science 300 (2003), 1148–1151.
42. Sokol, C.L., Luster, A.D., The chemokine system in innate immunity. Cold Spring Harb. Perspect. Biol., 7, 2015 a016303.
43. Szklarczyk, D., Gable, A.L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N.T., Morris, J.H., Bork, P., et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47:D1 (2019), D607–D613.
44. tenOever, B.R., The Evolution of Antiviral Defense Systems. Cell Host Microbe 19 (2016), 142–149.
45. Varble, A., Albrecht, R.A., Backes, S., Crumiller, M., Bouvier, N.M., Sachs, D., García-Sastre, A., tenOever, B.R., Influenza A virus transmission bottlenecks are defined by infection route and recipient host. Cell Host Microbe 16 (2014), 691–700.
46. Weiss, S.R., Navas-Martin, S., Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 69 (2005), 635–664.
47. Wickham, H., ggplot2: Elegant Graphics for Data Analysis. 2016, Springer.
48. Witten, D.M., Tibshirani, R., Hastie, T., A penalized matrix decomposition, with applications to sparse principal components and canonical correlation analysis. Biostatistics 10 (2009), 515–534.
49. Wolfel, R., Corman, V.M., Guggemos, W., Seilmaier, M., Zange, S., Muller, M.A., Niemeyer, D., Jones, T.C., Vollmar, P., Rothe, C., et al. Virological assessment of hospitalized patients with COVID-2019. Nature, 2020, 10.1038/s41586-020-2196-x Published online April 1, 2020.
50. Wu, F., Zhao, S., Yu, B., Chen, Y.M., Wang, W., Song, Z.G., Hu, Y., Tao, Z.W., Tian, J.H., Pei, Y.Y., et al. A new coronavirus associated with human respiratory disease in China. Nature 579 (2020), 265–269.
51. Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8 (2020), 420–422.
52. Yoshida, H., Lareau, C.A., Ramirez, R.N., Rose, S.A., Maier, B., Wroblewska, A., Desland, F., Chudnovskiy, A., Mortha, A., Dominguez, C., et al. The cis-Regulatory Atlas of the Mouse Immune System. Cell 176 (2019), 897–912.e20.
53. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al., China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 382 (2020), 727–733.